Skip to main content
. 2012 Aug 3;7(8):e42134. doi: 10.1371/journal.pone.0042134

Table 2. A. Body weight during the treatment.

A BW (g)
Treatment Day 1 Day 12 Day 19 Day 26 Day 33 Day 40 Day 47 Day 54 Day 61
Lean Veh 35.8±0.3* 35.2±0.4* 35.5±0.4* 36.1±0.4* 36.0±0.4* 36.0±0.5* 35.5±0.4* 37.4±0.3* 36.3±0.4*
DIO Veh 46.9±1.0 46.8±1.0 46.6±1.6 48.0±1.1 47.6±1.1 49.9±1.1 49.9±0.9 52.0±0.8 51.2±0.9
CB1 ASO 25mg/kg/wk 47.3±0.9 47.5±0.9 47.6±0.9 47.1±1.0 46.5±1.0 46.6±0.8* 45.9±1.0* 47.3±0.9* 46.1±1.0*
CB1 ASO 12.5mg/kg/wk 47.9±1.2 47.9±1.3 48.0±1.3 48.2±1.4 48.0±1.5 48.2±1.7 48.3±1.6 50.4±1.5 49.4±1.4
CB1 ASO 6.25mg/kg/wk 47.6±1.1 47.4±1.3 48.6±1.1 48.6±1.1 48.9±1.2 49.2±1.2 49.2±1.1 50.9±1.2 49.1±1.3
Control ASO 25mg/kg/wk 47.3±1.0 47.3±1.0 47.8±1.0 48.4±1.1 48.8±1.2 49.3±1.2 49.9±1.2 51.9±1.2 50.5±1.3
B BW (% of starting)
Treatment Day 1 Day 12 Day 19 Day 26 Day 33 Day 40 Day 47 Day 54 Day 61
DIO Veh 100±2.2 99.9±2.0 99.4±3.5 102.4±2.4 101.4±2.4 106.5±2.2 106.5±1.8 111.0±1.8 109.2±1.9
CB1 ASO 25mg/kg/wk 100±1.8 100.4±1.9 100.7±1.9 99.5±2.1 * 98.3±2.0* 98.5±1.7* 97.0±2.1 * 100.1±2.0* 97.6±2.0*
CB1 ASO 12.5mg/kg/wk 100±2.5 100±2.7 100.1±2.7 100.6±2.9 100.0±3.1 100.5±3.5 100.7±3.4 105.0±±3.2 102.9±2.9
CB1 ASO 6.25mg/kg/wk 100±2.4 99.5±2.8 100.2±2.2 102.1±2.4 102.6±2.5 103.4±2.4 103.3±2.4 106.9±2.4 103.3±2.8
Control ASO 25mg/kg/wk 100±2.0 100±2.1 101.0±2.1 102.3±2.3 103.2±2.5 104.3±2.5 105.4±2.6 109.8±2.5 106.8±2.7

B. Body weight change (% of the beginning body weight) during the treatment. One way ANOVA Dunnett’s multiple test compared to DIO Veh, *p<0.05.